Enhance COVID testing, ensure adequate care facilities in view of Kumbh: Centre to Uttarakhand

By: |
March 21, 2021 2:03 PM

"It has been noted that there is a potential of an upsurge in cases in the local population after the auspicious Shahi Snan days during the Kumbh Mela," the ministry said.

Kumbh Mela, Covid appropriate behaviour, Kumbh Mela, Shahi Snan, National Centre for Disease Control, potential covid surge in Kumbh Mela, Haridwar , uttrakhand Health ministerThe state has been informed that the daily testing numbers reported in Haridwar -- 50,000 Rapid Antigen tests and 5,000 RTPCR tests -- are not enough

Noting that there is a potential of an upsurge in COVID-19 cases during the Kumbh Mela, the Centre has written to Uttarakhand strongly highlighting the concerns raised by a high-level central team about the need for stringent measures to control the spread of the disease.

The central team led by the National Centre for Disease Control (NCDC) Director visited Uttarakhand on March 16-17 to review the medical and public health measures undertaken by the state for the ongoing Kumbh Mela in Haridwar, the Health Ministry said in a statement.

In his letter to the Uttarakhand Chief Secretary, Union Health Secretary Rajesh Bhushan has observed that more than 12 states in India have shown a surge in COVID-19 cases during the past few weeks, and pilgrims expected to visit Haridwar during the Kumbh Mela could also be from these states.

“It has been noted that there is a potential of an upsurge in cases in the local population after the auspicious Shahi Snan days during the Kumbh Mela,” the ministry said. “The secretary also noted that as per the report of the central team, 10-20 pilgrims and 10-20 locals are being reported positive every day.

“This positivity rate has the potential to rapidly turning to an upsurge in cases, given the expected large footfall during Kumbh,” the ministry said in its statement. The state has been informed that the daily testing numbers reported in Haridwar — 50,000 Rapid Antigen tests and 5,000 RTPCR tests — are not enough to effectively offset a huge number of expected pilgrim footfall.

It has been advised that the share of RTPCR tests being conducted at present needs to be significantly increased as per the ICMR guidelines to ensure that the pilgrims and local population is appropriately tested. The state government has been advised to follow scrupulously the SOPs issued by the ministry and display signage to disseminate the main points of these SOPs; increase awareness of self-reporting, especially among local population, in case of symptoms suggestive of COVID-19; and set up system for generating early warning signals in areas with susceptible population by monitoring trend of ARI/ ILI cases through Emergency Operational Centres.

It has also been urged to target significantly enhanced testing in potential high transmission areas, continue periodic testing of frontline workers before and after auspicious bathing days of the Kumbh and ensure operationalisation of adequate critical care treatment facilities. It has also been asked to ensure effective risk communication, by using all forms of media platforms, for strict adherence to COVID-appropriate behaviour.

“In case of surge in cases/super spreader events, promptly send samples for genome sequencing in consultation with NCDC,” the ministry said. The Union Health Secretary has urged the Uttarakhand government to take a stock of the public health measures being undertaken by the state in consonance with the aforesaid recommendations of the Health Ministry, the statement added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19: Govt calls for state-specific sero surveys
2Biocon Biologics partners Adagio Therapeutics for Covid-19 treatment
3No room for complacency in COVID-19 fight, absolute case numbers still high: MHA to states